Literature DB >> 8445814

The impact on infant birth weight and gestational age of cotinine-validated smoking reduction during pregnancy.

C Q Li1, R A Windsor, L Perkins, R L Goldenberg, J B Lowe.   

Abstract

OBJECTIVE: To evaluate the impact of cotinine-confirmed smoking reduction during pregnancy on infant birth weight and gestational age at birth.
DESIGN: Group analyses from a prospective, randomized smoking-cessation intervention trial using cotinine levels to assess smoking cessation and reduction.
SETTING: Four maternity clinics of Jefferson County Health Department in Birmingham, Ala. PATIENTS: A total of 803 pregnant smokers and 474 never smokers with a fetal gestational age of 32 weeks or less at the first prenatal visit to a clinic. MAIN OUTCOME MEASURES: Infant birth weight and gestational age at birth.
RESULTS: Infants who were born to women who quit smoking (quitters) had the highest mean birth weight (3371 +/- 581 g), followed by infants who were born to women who did not change smoking behavior (no changers) (3043 +/- 587 g). The mean infant birth weight of infants born to the quitters, adjusted by mother's age, race, height, weight at baseline, and gestational age at delivery was 241 g heavier than that among the no changers (P = .0008) and 167 g heavier than the reducers (P = .04). The adjusted mean infant birth weight of infants born to the reducers was 92 g heavier than that among the no changers (P = .08). White reducers with baseline cotinine levels greater than 100 ng/mL had infants who were 241 g heavier than did white no changers. A 220-g difference was also seen in black reducers with a baseline cotinine level of 100 ng/mL or less. Although smoking cessation increased infant gestational age at delivery by 1 week, smoking reduction had little effect.
CONCLUSION: Cotinine-validated smoking reduction rates were positively associated with an increase in infant birth weight. While smoking cessation must continue to be the primary objective for pregnant smokers, specific intervention methods should also be directed toward smoking reduction for women who cannot quit.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8445814

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  46 in total

1.  Quality of measurement of smoking status by self-report and saliva cotinine among pregnant women.

Authors:  N R Boyd; R A Windsor; L L Perkins; J B Lowe
Journal:  Matern Child Health J       Date:  1998-06

2.  Maternal smoking during pregnancy and severe antisocial behavior in offspring: a review.

Authors:  Lauren S Wakschlag; Kate E Pickett; Edwin Cook; Neal L Benowitz; Bennett L Leventhal
Journal:  Am J Public Health       Date:  2002-06       Impact factor: 9.308

Review 3.  Does smoking by pregnant women influence IQ, birth weight, and developmental disabilities in their infants? A methodological review and multivariate analysis.

Authors:  M C Ramsay; C R Reynolds
Journal:  Neuropsychol Rev       Date:  2000-03       Impact factor: 7.444

4.  Influence of smoking and snuff cessation on risk of preterm birth.

Authors:  Sachiko Baba; Anna-Karin Wikström; Olof Stephansson; Sven Cnattingius
Journal:  Eur J Epidemiol       Date:  2012-03-20       Impact factor: 8.082

Review 5.  Contingency management interventions for tobacco and other substance use disorders in pregnancy.

Authors:  Dennis J Hand; Jennifer D Ellis; Meagan M Carr; Diane J Abatemarco; David M Ledgerwood
Journal:  Psychol Addict Behav       Date:  2017-06-22

6.  Obstetricians and gynecologists' perceptions and use of nicotine replacement therapy.

Authors:  James H Price; Timothy R Jordan; Joseph A Dake
Journal:  J Community Health       Date:  2006-06

7.  Medicaid reimbursement for prenatal smoking intervention influences quitting and cessation.

Authors:  R Petersen; J M Garrett; C L Melvin; K E Hartmann
Journal:  Tob Control       Date:  2006-02       Impact factor: 7.552

Review 8.  Biomarkers to assess the utility of potential reduced exposure tobacco products.

Authors:  Dorothy K Hatsukami; Neal L Benowitz; Stephen I Rennard; Cheryl Oncken; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2006-08       Impact factor: 4.244

Review 9.  What do we know about the role of pharmacotherapy for smoking cessation before or during pregnancy?

Authors:  Cheryl A Oncken; H R Kranzler
Journal:  Nicotine Tob Res       Date:  2009-08-28       Impact factor: 4.244

10.  Correlation of Cotinine Levels with Use of Smokeless Tobacco (Mishri) among Pregnant Women and Anthropometry of Newborn.

Authors:  Praveen Ganganahalli; Asha Pratinidhi; Jyotsna Patil; Satish V Kakade
Journal:  J Clin Diagn Res       Date:  2017-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.